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1. Introduction 
The amino acid sequences of the pituitary hormone 
corticotropin (ACTH) from four different mammalian 
species (porcine [l] , ovine [2,3], bovine [4,5], and 
human [6] ) have been elucidated, some of them al- 
most twenty years ago. The proposed structures, how- 
ever, contained a few errors which remained undetect- 
ed until the amino acid sequences of porcine and 
human ACTH were recently corrected by two diffe- 
rent groups [7,8]. As a consequence of these studies 
C. H. Li was prompted to re-examine his earlier pro- 
posals for the ovine and bovine hormones [9]. In both 
cases, Edman degradation of the tryptic fragments 22- 
39 showed that the amino acid sequence 25-32 was 
not correct and therefore had to be revised. According 
to these new findings, the hormones of the two species 
should differ in position 25, with aspartic acid in ovine 
and asparagine in bovine ACTH. Glutamine has been 
proven to be present in both species in position 33 
[3,51. 
It is known from the early work on sheep ACTH 
that this compound is unstable under alkaline condi- 
tions and that it easily undergoes deamidation [lo]. 
The same applies to porcine and human ACTH, since 
both contain the very labile A&-GlyZ6 sequence. 
The revised structure postulated by Li [9] for sheep 
ACTH, however, could not explain this lability. It 
seemed therefore most probable to us that ACTH from 
this species should also contain asparagine in position 
25 instead of aspartic acid and thus should be identical 
with beef ACTH. 
The deamidation of asparagine peptides in alkaline 
conditions leads, via the succinimide derivatives as 
intermediates, to a mixture of (Y- and /I-aspartic pep- 
tides, in which the latter predominate. The difficulties 
H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys- 
1 21 
I 
F2 
Val-Tyr-Pro-Asp-Gly-Ala-Glu-Asp-Glu-Leu-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe-OH 
22 25 31 33 39 
VH2 
Ii -Asp-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu- 
25 31 33 
F2 YH2 
III -Asp-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu 
25 31 33 
Fig. 1. Amino acid sequences of the known corticotropins from mammalian species. I: Porcine; II: Human; III: Ovine and bovine. 
(Sequences l-24 and 34-39 of II and III as in I.) 
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in the sequence studies with ACTH peptides had quite 
clearly been caused by this deamidation, which had 
given rise to wrong results in the Edman degradation 
process from asparagine25 onwards. In order finally to 
settle the question of the amide group, we decided to 
isolate and compare both ovine and bovine ACTH, 
carefully avoiding alkaline conditions during the pre- 
paration and in the analytical procedures. The C-ter- 
minal tryptic fragments comprising the sequence 22- 
39 were used as key compounds for this work. In 
addition, the corresponding synthetic human frag- 
ment [ 1 l] with its known sequence (fig. 1, II) served 
as a reference compound. 
By means of electrophoretic and deamidation expe, 
riments, as well as by Edman degradation, we were able 
to prove that bovine and ovine ACTH are identical, 
both having asparagine in position 25. The only struc- 
tural difference between human ACTH and the ovine 
and bovine hormone is at position 33, which is occu- 
pied by glutamic acid in human, and by glutamine in 
ovine and bovine ACTH. 
2. Experimental 
2.1. Isolation procedures 
Ovine ACTH was isolated and converted to the 
fragment 22-39 in the following manner: Sheep 
pituitary glands were homogenized in 0.25 M saccha- 
rose and extracted with HCI-acetone at 0°C [12]. 
After removal of the residue by centrifugation, acetone 
was added to the supernate and the precipitate 
collected by centrifugation. Sodium chloride fraction- 
ation was performed as described by Papkoff and Li 
[ 131. The resulting precipitate was dissolved in 1 M 
AcOH, desalted by Sephadex G-SO, and freeze-dried. 
This material was further purified by absorption on 
CM-cellulose (Whatman CM 23) according to Homan 
and Ederzeel [ 141. Final purification of the crude 
ACTH was achieved by gel filtration on Sephadex G-SO 
using 1 M acetic acid as eluant, followed by counter- 
current distribution in the solvent system t-butanol- 
2% trifluoroacetic acid--chloroform-toluene (10: 10: 
1:l) [ll]. 
Tryptic cleavage of the purified ACTH was per- 
formed with 2.5% trypsin in 0.2 M ammonium acetate 
at pH 8 for 40 min at 38’C, acidification, lyophilisa- 
tion and fractionation by countercurrent distribution 
in the system n-butanol---acetic acid-water (4: 1: 5). 
After 200 steps the pure fragment 22-39 was obtained 
from tubes 105-I 24; Kzl.5. 
Bovine ACTH was isolated, purified and degraded to 
the fragment 22-39 as outlined for the ovine ACTH 
with the exception that acetone powder of beef 
anterior pituitary glands, purchased from Miles Labo- 
ratories (Kankakee, Ill., USA) was used as starting 
material. 
Isolation and purification of ovine and bovine 
ACTH were monitored by the in vitro bioassay 
according to Saffran and Schally [15] and by thin- 
layer chromatography. 
2.2. A&y tical methods 
Electrophoreses were performed with 10 pg 
samples of peptides 22-39 on cellulose-coated plates 
(20 X 20 cm) in 0.05 M phosphate buffer, pH 7.7, 
for 1 hr at 30 V/cm. The spots were stained by the 
chlorination method. 
In order to determine the rate of deamidation, 0.2% 
peptide solutions in IN NH3 were left at 25°C for 
various time intervals, evaporated to dryness, dissolved 
in 10% pyridine and analysed by electrophoresis. 
Manual Edman degradations were carried out in 
micro-centrifuge tubes. 300 Dg of the peptide 22-39, 
dissolved in 40 11 pyridine-Hz0 (1: l), were incu- 
bated under N2 with 25% phenylisothiocyanate in 
pyridine for 1 hr at 40°C. The mixture was extracted 
twice, each time with 200 ~1 benzene, and the aqeous 
phase dried over PZOS and KOH. The residue was 
treated for 30 min at 25’C* with 10 ~1 of trifluoro- 
acetic acid and then evaporated by spreading it in 
vacua as a thin film on the glass surface. This residue 
was twice extracted for 5 min with 100 ~1 of benzene- 
1,2-dichloroethane (2: l), the insoluble material dried 
over KOH and used for the next degradation step. The 
organic extract was evaporated, treated with 20 ,uI 1 N 
HCl under Nz for 10 min at 80°C and dried. The 
PTH-amino acid residue was taken up in 10 ~1 of 
ethylacetate-acetone (1: l), and 1 to 4 ~1 thereof 
spotted on silica gel thin-layer plates (Antec SC 254) 
containing fluorescence indicator. The solvent systems 
chloroform-methanol (95:5) and chloroform-metha- 
nol-acetic acid (90: 10:3) were used, the latter per- 
* In the third step with C-terminal proline, the temperature 
was raised to 40°C. 
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mitting the differentiation of the PTH-derivatives of 
Asp, Asn, Glu, and Gln. The spots were visible by 
their UV-absorption at 254 nm. 
3. Results and discussion 
Comparison of the electrophoretic mobility of the 
C-terminal fragmenrs 22-39 at pH 7.7 gave the follow- 
ing results: ovine 4.9 (5.9); bovine 4.9 (5.9); synthetic 
human 5.9 (6.9). (The figures indicate migration 
distances in cm towards the anode, and the values of 
the deamidated forms are given in brackets.) These re- 
lationships prove that the ovine and bovine fragments 
both have an identical number of free carboxylic 
groups, and that after deamidation this number is the 
same as in the non-deamidated human reference pep- 
tide, which contains six free carboxylic and one car- 
boxamide group. The non-deamidated ovine and 
bovine fragments therefore contain two amide side 
chains. The deamidation experiments further showed 
identical half-lives (approx. 50 min) in 1 N ammonia 
at 25°C for all three compounds, indicating the 
presence of the extremely labile Asn2’ -Gly26 se- 
quence. In addition, this sequence was substantiated 
by Edman degradation of the ovine and bovine frag- 
ments 22-39, which was carried out in five steps. 
PTH-asparagine, accompanied by a small amount of 
ETH-aspartic acid, was the product of both peptides 
after the fourth step, followed by PTH-glycine in the 
next one. 
These results confirmed our assumption, i.e. the 
structure of the recently revised sequence of ovine 
ACTH [9] has to be corrected by adding an extra 
amide group in position 25. Thus, ovine and bovine 
ACTH are identical (III) and differ from the human 
hormone (II) only in position 33, which is glutamic 
acid in human-, but glutamine in ovine- and bovine- 
ACTH. The porcine type (I) is similar to the human 
one with regard to the single amide group in position 
25, but contains leucine31 instead of serinej’ . These 
minor differences are located in the C-terminal part 
of the molecule which is not essential for the corti- 
costeroidogenic activity of the hormone. 
It is interesting to consider also in this comparison 
the only non-mammalian ACTH known so far: in 
dogfish ACTH [ 161 we find the same amino acids in 
position 25 and 33 as in the human and porcine types, 
despite a large number of alterations which affect 
mainly the carboxyl end. 
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